NitinRohatgiMDMBA
Oncology • Sacramento, CABreast Cancer, Genitourinary Oncology
Medical Director, Breast Cancer Program, Sutter Medical Center Sacramento
Dr. Rohatgi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 L St, #300
Sacramento, CA 95816Phone+1 916-453-3300
Summary
- Dr. Nitin Rohatgi is an oncologist based in Sacramento, CA, specializing in breast cancer and genitourinary oncology. He completed his residency in internal medicine at UMass Chan Medical School and a fellowship in hematology and medical oncology at the University of Cincinnati Medical Center. His expertise includes breast and GU malignancies. He has published research in prominent journals like JCO Precision Oncology and Annals of Surgical Oncology, focusing on topics such as breast cancer and prostate cancer. Dr. Rohatgi has been involved in clinical trials related to breast cancer treatments and holds honors such as recognition as a Super Doctor, Best Doctors in Sacramento, and inclusion in Marquis Who's Who 2024.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2002
UMass Chan Medical SchoolResidency, Internal Medicine, 1993 - 1996
All India Institute of Medical SciencesClass of 1990
Certifications & Licensure
CA State Medical License 2002 - 2026
OH State Medical License 1998 - 2004
FL State Medical License 1996 - 2002
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsSunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-02-01 - 2 citationsNivolumab Plus Ipilimumab in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam
JCO Precision Oncology. 2023-09-01 - 5 citationsOlaparib in Patients With Metastatic Prostate Cancer With/Mutation: Results From the TAPUR Study.Eddy S Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat
JCO Precision Oncology. 2023-02-01
Professional Memberships
- Member
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
